KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Assets Average: 2018-2025

Historic Assets Average for Aurinia Pharmaceuticals (AUPH) over the last 8 years, with Sep 2025 value amounting to $515.0 million.

  • Aurinia Pharmaceuticals' Assets Average fell 3.99% to $515.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $515.0 million, marking a year-over-year decrease of 3.99%. This contributed to the annual value of $549.4 million for FY2024, which is 7.83% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Assets Average of $515.0 million as of Q3 2025, which was up 2.25% from $503.7 million recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' Assets Average ranged from a high of $552.0 million in Q3 2023 and a low of $373.2 million during Q3 2021.
  • In the last 3 years, Aurinia Pharmaceuticals' Assets Average had a median value of $527.7 million in 2025 and averaged $522.8 million.
  • In the last 5 years, Aurinia Pharmaceuticals' Assets Average surged by 37.77% in 2021 and then declined by 12.15% in 2023.
  • Aurinia Pharmaceuticals' Assets Average (Quarterly) stood at $451.7 million in 2021, then climbed by 6.17% to $479.6 million in 2022, then climbed by 15.01% to $551.5 million in 2023, then declined by 0.28% to $550.0 million in 2024, then fell by 3.99% to $515.0 million in 2025.
  • Its Assets Average stands at $515.0 million for Q3 2025, versus $503.7 million for Q2 2025 and $527.7 million for Q1 2025.